Market Cap 1.24B
Revenue (ttm) 631.45M
Net Income (ttm) 69.19M
EPS (ttm) N/A
PE Ratio 6.60
Forward PE 6.17
Profit Margin 10.96%
Debt to Equity Ratio 2.52
Volume 447,800
Avg Vol 345,070
Day's Range N/A - N/A
Shares Out 31.50M
Stochastic %K 79%
Beta 0.68
Analysts Strong Sell
Price Target $44.60

Company Profile

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-dete...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 781 713 3699
Address:
100 Technology Center Drive, Suite 300, Stoughton, United States
stockpicker63
stockpicker63 Aug. 15 at 6:04 PM
Nice profits on the free tips van Swingstocktraders. $AUPH now +34%, $PLUG now +16%, $ELAN +5%, $COLL +5.5%, $KOD +18%.
1 · Reply
net0trader
net0trader Aug. 13 at 6:56 PM
$ANIP $CELC $COLL I am out of all 3 names ..
0 · Reply
net0trader
net0trader Aug. 13 at 1:56 AM
$ANIP $CELC $COLL these really exceeded my expectations... Quite some momentum
0 · Reply
stockpicker63
stockpicker63 Aug. 11 at 1:57 PM
Stocks to watch now! $COLL and $ELAN
0 · Reply
JarvisFlow
JarvisFlow Aug. 11 at 11:00 AM
HC Wainwright & Co. updates rating for Collegium Pharmaceutical ( $COLL ) to Buy, target set at 44.
0 · Reply
net0trader
net0trader Aug. 10 at 8:38 PM
Some of the XBI names I am watching this week $ANIP $CELC $COLL . Cc @RonIsWrong
1 · Reply
d_risk
d_risk Aug. 7 at 2:28 PM
$COLL - Collegium Pharmaceutical Inc. Common Stock - 10Q - Updated Risk Factors COLL’s 10-Q Risk Factors section returns with expanded, detailed disclosures covering business, financial, commercialization, IP, third-party, legal, regulatory, market, and stock risks, adding a comprehensive risk summary without removing prior content. #Pharmaceuticals #MarketVolatility #IntellectualProperty #RegulatoryCompliance #RiskManagement 🟢 Added 🟠 Removed https://d-risk.ai/COLL/10-Q/2025-08-07
0 · Reply
tommynos
tommynos Aug. 7 at 1:20 PM
$COLL 60$ =4.5x ebitda
0 · Reply
Stefan100
Stefan100 Aug. 7 at 12:02 PM
$COLL earnings and guidance looked good https://ir.collegiumpharma.com/news-releases/news-release-details/collegium-reports-second-quarter-2025-financial-results-raises
2 · Reply
Stefan100
Stefan100 Jul. 8 at 3:31 PM
$COLL my research below. Pretty timely as the company is launching another buyback program of $150MM or 15% of market cap https://seekingalpha.com/article/4765962-collegium-pharmaceuticals-shareholders-might-be-in-for-a-pain-free-2025
2 · Reply
Latest News on COLL
Collegium Announces $150 Million Share Repurchase Program

Jul 7, 2025, 8:00 AM EDT - 6 weeks ago

Collegium Announces $150 Million Share Repurchase Program


Collegium to Participate in Upcoming Investor Conferences

May 19, 2025, 4:01 PM EDT - 3 months ago

Collegium to Participate in Upcoming Investor Conferences


Collegium Provides 2025 Financial Guidance and Business Update

Jan 8, 2025, 8:00 AM EST - 8 months ago

Collegium Provides 2025 Financial Guidance and Business Update


Collegium Reports Record Third Quarter 2024 Financial Results

Nov 7, 2024, 4:02 PM EST - 10 months ago

Collegium Reports Record Third Quarter 2024 Financial Results


Collegium Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 4:01 PM EDT - 1 year ago

Collegium Reports Second Quarter 2024 Financial Results


Collegium Reports First Quarter 2024 Financial Results

May 9, 2024, 4:02 PM EDT - 1 year ago

Collegium Reports First Quarter 2024 Financial Results


Top 10 Small-Cap Stocks (SA Quant)

Mar 12, 2024, 5:00 AM EDT - 1 year ago

Top 10 Small-Cap Stocks (SA Quant)

ANIP APOG BASE BLBD GCT PLMR RAMP


Collegium Reports Third Quarter 2023 Financial Results

Nov 7, 2023, 4:01 PM EST - 1 year ago

Collegium Reports Third Quarter 2023 Financial Results


Collegium Pharmaceutical: Delivering On Promises

Oct 24, 2023, 2:59 PM EDT - 1 year ago

Collegium Pharmaceutical: Delivering On Promises


stockpicker63
stockpicker63 Aug. 15 at 6:04 PM
Nice profits on the free tips van Swingstocktraders. $AUPH now +34%, $PLUG now +16%, $ELAN +5%, $COLL +5.5%, $KOD +18%.
1 · Reply
net0trader
net0trader Aug. 13 at 6:56 PM
$ANIP $CELC $COLL I am out of all 3 names ..
0 · Reply
net0trader
net0trader Aug. 13 at 1:56 AM
$ANIP $CELC $COLL these really exceeded my expectations... Quite some momentum
0 · Reply
stockpicker63
stockpicker63 Aug. 11 at 1:57 PM
Stocks to watch now! $COLL and $ELAN
0 · Reply
JarvisFlow
JarvisFlow Aug. 11 at 11:00 AM
HC Wainwright & Co. updates rating for Collegium Pharmaceutical ( $COLL ) to Buy, target set at 44.
0 · Reply
net0trader
net0trader Aug. 10 at 8:38 PM
Some of the XBI names I am watching this week $ANIP $CELC $COLL . Cc @RonIsWrong
1 · Reply
d_risk
d_risk Aug. 7 at 2:28 PM
$COLL - Collegium Pharmaceutical Inc. Common Stock - 10Q - Updated Risk Factors COLL’s 10-Q Risk Factors section returns with expanded, detailed disclosures covering business, financial, commercialization, IP, third-party, legal, regulatory, market, and stock risks, adding a comprehensive risk summary without removing prior content. #Pharmaceuticals #MarketVolatility #IntellectualProperty #RegulatoryCompliance #RiskManagement 🟢 Added 🟠 Removed https://d-risk.ai/COLL/10-Q/2025-08-07
0 · Reply
tommynos
tommynos Aug. 7 at 1:20 PM
$COLL 60$ =4.5x ebitda
0 · Reply
Stefan100
Stefan100 Aug. 7 at 12:02 PM
$COLL earnings and guidance looked good https://ir.collegiumpharma.com/news-releases/news-release-details/collegium-reports-second-quarter-2025-financial-results-raises
2 · Reply
Stefan100
Stefan100 Jul. 8 at 3:31 PM
$COLL my research below. Pretty timely as the company is launching another buyback program of $150MM or 15% of market cap https://seekingalpha.com/article/4765962-collegium-pharmaceuticals-shareholders-might-be-in-for-a-pain-free-2025
2 · Reply
Itinerant
Itinerant Jul. 7 at 3:27 PM
$COLL I am impressed with the company's share buyback. They are not wrong. The stock is meaningfully under valued and the analysts' target of $41 is appropriate. I do worry about the legal issues, but the discount rate at $41 is 19%, which is rather substantial anyway.
0 · Reply
ISHARETRADEALERTS
ISHARETRADEALERTS Jul. 7 at 12:00 PM
$COLL - Collegium Announces $150 Million Share Repurchase Program
0 · Reply
Itinerant
Itinerant Jul. 6 at 7:54 PM
$COLL I did a cursory analysis of this company, and while it looks somewhat cheap, I suspect that the market is concerned about the lawsuits. I appreciate that the company is buying in the stock, but the lawsuits are a risky overhang. I guess that is holding the stock down. What do you think?
1 · Reply
jewell69
jewell69 Jun. 6 at 4:34 PM
$COLL got opium ? (a spoof on tv ads, got milk) took profits, but all $IBB $XBI is (APPARENTLY) up today 6/6/25 tryin 2 sell $FRSH 15.72 now b a .63 x .64 12:31 pm EDT
0 · Reply
jewell69
jewell69 Jun. 3 at 5:47 PM
$COLL TRYIN 2 ChASE/ BUY 29.27 LAST TIME WE TOOK PROFITS WAS B4 NICE EARNIN ON 5/8/25 STOCK IS UP SINCE 5/8, BUT 10 DAY gRAPh IS DOWN 2 EYE LAShES Symbol description COLLEGIUM PHARMACEUTICAL INC COM Type Cash Shares -222.000 Price $27.14 Amount $6,023.80 Fees $0.17 Settlement date Apr-29-2025
0 · Reply
jewell69
jewell69 May. 15 at 12:39 AM
$COLL PAIN MEDICINE, seriously. I like 2 joke got opium ? reminds me of Sean Penn / Madonna movie 1986 Shanghai Surprise - takes place in occupied China $MCHI (occupied by $EWJ Japan in 1936) movie starts w/ just SOME of China occupied; but another huge swath of land is imminently being taken over. Opium kingpin tries to move 1100 pounds of opium to safer, quieter remaining $MCHI land. But, Madonna wants all of it.
0 · Reply
jewell69
jewell69 May. 15 at 12:32 AM
$COLL 5/14 CLOSE 29.07 -2.45% TODAY !! 05/13/2025 Sell Trade Details COLL COLLEGIUM PHARMACEUTICAL 60 $29.779 $0.01 $1,786.73 04/01/2025 Buy Trade Details COLL COLLEGIUM PHARMACEUTICAL 60 $29.55 -$1,773.00 01/07/2025 Sell Trade Details COLL COLLEGIUM PHARMACEUTICAL 200 $29.12 $0.19 $5,823.81 01/06/2025 Buy Trade Details COLL COLLEGIUM PHARMACEUTICAL 200 $28.62 -$5,724.00
0 · Reply
jewell69
jewell69 May. 10 at 8:18 PM
$COLL after close on 5/8 Reports Q1 (Mar) earnings of $1.49 per share, excluding non-recurring items, $0.06 better than the FactSet Consensus of $1.43; revenues rose 22.7% year/year to $177.76 mln vs the $171.95 mln FactSet Consensus. Co reaffirms guidance for FY25, sees FY25 revs of $735-$750 mln vs. $741.47 mln FactSet Consensus 5/9 up 5.94% to 28.89 too bad I paid 29.55 on 4/1 (b4 all _ell broke loose on 4/7 or 4/9 = bottom of market, remember )
0 · Reply
JarvisFlow
JarvisFlow May. 9 at 2:34 PM
Piper Sandler has updated their rating for Collegium Pharmaceutical ( $COLL ) to Neutral with a price target of 37.
0 · Reply
Estimize
Estimize May. 8 at 3:13 PM
Wall St is expecting 1.61 EPS for $COLL Q2 [Reporting 07/31 AMC] http://www.estimize.com/intro/coll?chart=historical&metric_name=eps&utm_co
0 · Reply
Estimize
Estimize May. 6 at 12:24 PM
Wall St is expecting 1.43 EPS for $COLL Q1 [Reporting 05/08 AMC] http://www.estimize.com/intro/coll?chart=historical&metric_name=eps&utm_co
0 · Reply
jewell69
jewell69 Apr. 28 at 2:42 PM
$COLL sold just now 4/28 11:39 am EDT Type Cash Shares -222.000 Price $27.14 Amount $6,023.80 Fees $0.17 Settlement date Apr-29-2025 BOT 4/23 Type Cash Shares +222.000 Price $26.23 Amount -$5,823.06 Settlement date Apr-24-2025
0 · Reply